Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, open-labeled, positive controlled phase 2&3 combined study
to evaluate the safety and efficacy of weekly Y-shape pegylated somatropin, compared to daily
somatropin (Norditropin®), in prepubertal, treatment-naive children with growth hormone
deficiency.